Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W8JE
|
|||
Former ID |
DPR000134
|
|||
Drug Name |
Depudecin
|
|||
Synonyms |
(1R)-1-[(2S,3S)-3-[(E)-2-[(3S)-3-[(1R)-1-hydroxyethyl]oxiran-2-yl]ethenyl]oxiran-2-yl]prop-2-en-1-ol; 139508-73-9
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Preclinical | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H16O4
|
|||
Canonical SMILES |
CC(C1C(O1)C=CC2C(O2)C(C=C)O)O
|
|||
InChI |
1S/C11H16O4/c1-3-7(13)11-9(15-11)5-4-8-10(14-8)6(2)12/h3-13H,1H2,2H3/b5-4+/t6-,7-,8+,9+,10+,11+/m1/s1
|
|||
InChIKey |
DLVJMFOLJOOWFS-INMLLLKOSA-N
|
|||
CAS Number |
CAS 139508-73-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:64143
|
References | Top | |||
---|---|---|---|---|
REF 1 | HDAC inhibitors repress the polycomb protein BMI1. Cell Cycle. 2010 Jul 15; 9(14): 2722-2730. | |||
REF 2 | Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. Anticancer Agents Med Chem. 2007 Sep;7(5):576-92. | |||
REF 3 | Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006 Sep;5(9):769-84. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.